Spineology has received US Food and Drug Administration (FDA ) clearance for its new Rampart line of Interbody fusion implants.

The interbody fusion system is incorporated with implantation equipment designed to enhance a surgeon’s ability to position the implant within the disc space.

The Rampart line will feature a variety of implant configurations, lengths and heights providing the surgeon with several options to fit patient needs.

The company is committed to increasing procedural efficiency, reducing surgical morbidity and accelerating patient recovery.

 

 

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Medical Device Network Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Medical Device Network Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now